New
Emerging drugs for the treatment of vitiligo
Our co-authored paper titled Emerging drugs for the treatment of vitiligo has been published in the journal Expert Opinion on Emerging Drugs.
This study comprehensively summarizes the current concepts in the pathogenesis of vitiligo with special focus on the cytokine and signaling pathways, which are the targets for newer drugs. JAK kinase signaling pathways and the cytokines involved are the focus of vitiligo treatment in current research, followed by antioxidant and repigmenting mechanisms, basic fibroblast growth factors, afamelanotide and targeted immunotherapy.
For more information about emerging treatments for vitiligo, check out Drug Pipelines or Trials Hub sections of our website.
We also recommend reading our exclusive Vitiligo Drug Pipeline Analysis and Market Insights.
FAQOther Questions
- Is there a traditional medicine to treat vitiligo?
Traditional remedies can be helpful for managing stress or general metabolic health, but when it comes to vitiligo, the evidence is limited. While some natural supplements provi...
- Is there a special diet for vitiligo?
Recent research highlights the potential of diet and nutrition in managing vitiligo, offering an alternative where traditional therapies may be lacking. However, the relationshi...
- Why Does the IRS Still Show an Old Revocation for VR Foundation?
IRS Status · A Short FAQ The old entry records the past. Publication 78 shows where VR Foundation stands today. Updated August 2026 · EIN 45-2498489 Tax records are rarely elega...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.